Prils Market - Top Companies and Manufacturers

Companies Dominating the Prils Market

Teva Pharmaceuticals Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boehringer Ingelheim International GmbH
Sun Pharmaceuticals Industries Ltd.
Pfizer Inc.
Mylan N.V
F. Hoffmann-La Roche Ltd.
Novartis AG
Manus Aktteva Biopharma LLP
Canagen Pharmaceuticals Inc.
Lupin Limited

Browse Key Market Insights with Data Illustration:

Prils Market Size - Growth Forecast Report 2037

In the News

Lupin Limited entered into a contract with Medis for Lupin’s orphan drug NaMuscla (mexiletine). Further, for the symptomatic management of people with non-dystrophic myotonic (NDM) diseases, Medis will market NaMuscla in Central and Eastern European nations.
Novartis AG collaborated with Dr. Reddy's Laboratories which is exclusive for certain of its well-known medications, such as the Voveran range, the Calcium range, and Methergine. Further, the agreement aims to increase patient’s access to these medications beyond present geographic boundaries.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of prils is evaluated at USD 2.51 billion.

The prils market size was valued at USD 2.27 billion in 2024 and is expected to reach USD 5.08 billion by 2037, expanding at around 6.4% CAGR during the forecast period i.e., between 2025-2037. Rising geriatric population and the growing incidences of cardiovascular diseases will boost the market growth.

Europe industry is predicted to account for largest revenue share of 31% by 2037, driven by increasing initiatives to assist the expansion of generic medications through pricing and reimbursement in the region.

The major players in the market are Teva Pharmaceuticals Industries Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Mylan N.V, F. Hoffmann-La Roche Ltd., Novartis AG, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Lupin Limited

Prils Market - Top Companies and Manufacturers

Companies Dominating the Prils Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the prils market?

What are the factors driving the prils landscape?

Which region held the largest prils industry share?

Who are the key players in the prils sector?